OXYTOCIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Oxytocin, and when can generic versions of Oxytocin launch?
Oxytocin is a drug marketed by Dr Reddys, Fresenius Kabi Usa, Hikma, Hikma Farmaceutica, Sagent Pharms Inc, and Abbott. and is included in six NDAs.
The generic ingredient in OXYTOCIN is oxytocin. There are eleven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the oxytocin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Oxytocin
A generic version of OXYTOCIN was approved as oxytocin by HIKMA on January 10th, 2007.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for OXYTOCIN?
- What are the global sales for OXYTOCIN?
- What is Average Wholesale Price for OXYTOCIN?
Summary for OXYTOCIN
US Patents: | 0 |
Applicants: | 6 |
NDAs: | 6 |
Finished Product Suppliers / Packagers: | 4 |
Raw Ingredient (Bulk) Api Vendors: | 59 |
Clinical Trials: | 762 |
Patent Applications: | 5,144 |
Drug Prices: | Drug price information for OXYTOCIN |
What excipients (inactive ingredients) are in OXYTOCIN? | OXYTOCIN excipients list |
DailyMed Link: | OXYTOCIN at DailyMed |
Recent Clinical Trials for OXYTOCIN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University Hospital, Gentofte, Copenhagen | N/A |
University of Colorado, Denver | Phase 2 |
Karolinska Institutet | Phase 2 |
Pharmacology for OXYTOCIN
Drug Class | Oxytocic |
Physiological Effect | Increased Uterine Smooth Muscle Contraction or Tone |
Medical Subject Heading (MeSH) Categories for OXYTOCIN
Anatomical Therapeutic Chemical (ATC) Classes for OXYTOCIN
US Patents and Regulatory Information for OXYTOCIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dr Reddys | OXYTOCIN | oxytocin | INJECTABLE;INJECTION | 077453-001 | Jan 24, 2008 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Hikma | OXYTOCIN | oxytocin | INJECTABLE;INJECTION | 018243-002 | Jan 10, 2007 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Fresenius Kabi Usa | OXYTOCIN | oxytocin | INJECTABLE;INJECTION | 018248-002 | Approved Prior to Jan 1, 1982 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Abbott | OXYTOCIN 10 USP UNITS IN DEXTROSE 5% | oxytocin | INJECTABLE;INJECTION | 019185-003 | Mar 29, 1985 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Hikma Farmaceutica | OXYTOCIN | oxytocin | INJECTABLE;INJECTION | 200219-001 | Feb 13, 2013 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Abbott | OXYTOCIN 5 USP UNITS IN DEXTROSE 5% | oxytocin | INJECTABLE;INJECTION | 019185-001 | Mar 29, 1985 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |